Recent Updates
Recently added Catalysts
INO Positive Sentiment

INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025

Wednesday, March 12, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: INOVIO has announced that it will report its fourth quarter and year-end financial results for 2024 on March 18, 2025. Following the release, the company will host a live conference call at 4:30 p.m. ET to discuss the financial outcomes and offer a general business update. The event will be available online, and participants will have the opportunity to engage in a Q&A session. The webcast will be archived for 90 days for later access.
Price reaction · baseline $1.95 (2025-03-11 close) · hit after-hours · 1 other INO headline(s) in the window, move may be shared
day 0 close
+5.1%
day 1
-1%
day 3 · peak
+8.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • INOVIO is focused on innovative DNA medicines for serious diseases.
  • The upcoming conference call will provide insights into financial results.
  • The webcast allows for broad access to information and Q&A with analysts.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~6 mo
High dilution risk
Lead asset
VGX-410
Phase 2 · Hepatitis C Virus Infection

Full Press Release Details

PLYMOUTH MEETING, Pa., March 12, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious diseases, today announced that fourth quarter and year-end 2024 financial results will be released after the market close on March 18, 2025. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update.
The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancers, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Frequently Asked Questions

When will INOVIO release its Q4 2024 financial results?

INOVIO will release its Q4 2024 financial results on March 18, 2025.

What will happen after the financial results are released?

A live conference call and webcast will take place at 4:30 p.m. ET following the release.

How can I access the live webcast for the INOVIO event?

The live webcast is available at http://ir.inovio.com/events-and-presentations/default.aspx.

Is the INOVIO webcast interactive?

Yes, it includes a live Q&A session with analysts during the event.

How long will the INOVIO webcast be available for replay?

The webcast will be archived and accessible for replay for 90 days.

ShareAdd on Google
Tags: INO Viatris Investor Conferences Healthcare INOVIO financial results biotechnology HPV DNA medicines
Last updated: Mar 12, 2025

Biotech snapshot

Cash runway
$37M liquidity · $6M/mo burn
~6 mo
High dilution risk
Lead asset
VGX-410Phase 2
Hepatitis C Virus Infection →